Effect of infusion of vasoactive intestinal peptide (VIP)-antisense oligodeoxynucleotide into the third cerebral ventricle above the hypothalamic suprachiasmatic nucleus on the hyperglycemia caused by intracranial injection of 2-deoxy-D-glucose in rats

Neurosci Lett. 1998 Dec 4;257(3):135-8. doi: 10.1016/s0304-3940(98)00831-3.

Abstract

We examined the effect of the infusion of a vasoactive intestinal peptide (VIP) antisense oligodeoxynucleotide into the third cerebral ventricle above the hypothalamic suprachiasmatic nucleus (SCN) using osmotic minipump for 3 days (0.2 nmol/ml per h) on the hyperglycemic response to intracerebroventricular injection of 2-deoxy-D-glucose (2DG) (80 micromol) in rats. After the infusion of the VIP antisense the inhibition of VIP expression in the SCN was observed in association with suppressions of the hyperglycemia, hyperglucagonemia and relative hypoinsulinemia due to the 2DG injection. Furthermore, additional intracranial injection of VIP (4 nmol) restored these responses to the 2DG injection in rats treated with the VIP antisense. These findings suggest that VIP neurons in the SCN are involved in the regulation of glucose metabolism.

MeSH terms

  • Animals
  • Cerebral Ventricles / drug effects*
  • Cerebral Ventricles / metabolism
  • Deoxyglucose / toxicity*
  • Hyperglycemia / chemically induced*
  • Hyperglycemia / drug therapy
  • Hyperglycemia / metabolism*
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Infusion Pumps, Implantable
  • Injections, Intraventricular
  • Male
  • Oligonucleotides, Antisense / administration & dosage*
  • Oligonucleotides, Antisense / genetics
  • Rats
  • Rats, Wistar
  • Suprachiasmatic Nucleus / drug effects
  • Suprachiasmatic Nucleus / metabolism
  • Vasoactive Intestinal Peptide / administration & dosage*
  • Vasoactive Intestinal Peptide / genetics*

Substances

  • Oligonucleotides, Antisense
  • Vasoactive Intestinal Peptide
  • Deoxyglucose